← Leaderboards
Patrick Breheny
University Of Iowa
$1,404,806
Attributed
$4,998,633
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $655.3K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,998,633 · 1
By mechanism
R01$4,998,633 · 1
Top collaborators
- Carla M Nester8 shared
- Richard J Smith8 shared
- Michael John Schnieders5 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Richard J Smith$33,390,035
- Robert Foster Mullins$9,156,220
- Budd A Tucker$8,644,636
- Carla M Nester$1,404,806
- Michael John Schnieders$2,340,118
Others in their field
Other Emerging Leaders on “Proteins”
- John Damon Chodera · Sloan-Kettering Inst Can Research$50,971,767
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$40,723,314
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
Research focus
ProteinsDepositionMedicalPredictive ModelingHigh RiskSpecificityGeneticLongitudinal StudiesGenesPredict Clinical OutcomeCaringGrantKidneyRenal Glomerular DiseaseAlternative Complement PathwayEffective TherapyKidney FailureComplementAutoantibodiesFoundationsGene ComplementationFunctional DisorderKidney BiopsyIndolent
Grant awards (8)
C3 Glomerulopathy -- A Collaborative Study$577,430
R01 · FY2025 · DK
C3 Glomerulopathy -- A Collaborative Study$629,064
R01 · FY2024 · DK
C3 Glomerulopathy -- A Collaborative Study$655,274
R01 · FY2023 · DK
C3 Glomerulopathy -- A Collaborative Study$627,373
R01 · FY2021 · DK
C3 Glomerulopathy -- A Collaborative Study$627,373
R01 · FY2020 · DK
C3 Glomerulopathy -- A Collaborative Study$627,373
R01 · FY2019 · DK
C3 Glomerulopathy -- A Collaborative Study$627,373
R01 · FY2018 · DK
C3 Glomerulopathy -- A Collaborative Study$627,373
R01 · FY2017 · DK